Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer

J Clin Oncol. 2006 Nov 20;24(33):5330-1. doi: 10.1200/JCO.2006.08.1083.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antiemetics / administration & dosage
  • Antiemetics / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Carcinoma, Ductal, Breast / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Doxorubicin / administration & dosage
  • Female
  • Fever / etiology
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Middle Aged
  • Neutropenia / chemically induced
  • Neutropenia / complications
  • Paclitaxel / administration & dosage
  • Pneumonia, Pneumocystis / diagnosis*
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Pneumocystis / etiology
  • Polyethylene Glycols
  • Prednisone / therapeutic use
  • Recombinant Proteins
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antiemetics
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Dexamethasone
  • Doxorubicin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Cyclophosphamide
  • Paclitaxel
  • Filgrastim
  • Prednisone